The Role of Two Human Milk Oligosaccharides, 2'-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition

Human breast milk contains numerous biomolecules. Human milk oligosaccharides (HMOs) are the third most abundant component of breast milk, after lactose and lipids. Amongst the synthetized HMOs, 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT) are widely studied and are considered...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric gastroenterology, hepatology & nutrition 2019, Hepatology & Nutrition, 22(4), , pp.330-340
Main Authors: Hegar, Badriul, Wibowo, Yulianti, Basrowi, Ray Wagiu, Ranuh, Reza Gunadi, Sudarmo, Subianto Marto, Munasir, Zakiudin, Atthiyah, Alpha Fardah, Widodo, Ariani Dewi, Supriatmo, Kadim, Muzal, Suryawan, Ahmad, Diana, Ninung Rose, Manoppo, Christy, Vandenplas, Yvan
Format: Article
Language:English
Subjects:
Review
소아과학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Human breast milk contains numerous biomolecules. Human milk oligosaccharides (HMOs) are the third most abundant component of breast milk, after lactose and lipids. Amongst the synthetized HMOs, 2'-fucosyllactose (2'-FL) and lacto-N-neotetraose (LNnT) are widely studied and are considered safe for infant nutrition. Several studies have reported the health benefits of HMOs, which include modulation of the intestinal microbiota, anti-adhesive effect against pathogens, modulation of the intestinal epithelial cell response, and development of the immune system. The amount and diversity of HMOs are determined by the genetic background of the mothers (HMO secretors or non-secretors). The non-secretor mothers secrete lower HMOs than secretor mothers. The breastfed infants of secretor mothers gain more health benefit than those of non-secretor mothers. In conclusion, supplementation of infant formula with 2'-FL and LNnT is a promising innovation for infant nutrition.
ISSN:2234-8646
2234-8840
DOI:10.5223/pghn.2019.22.4.330